Amir
Abbas Mokhtarieh Amir, Daejeon KR
Patent application number | Description | Published |
---|---|---|
20130149374 | Asymmetric Liposomes for the Highly Efficient Encapsulation of Nucleic Acids and Hydrophilic Anionic Compounds, and Method for Preparing Same - The present invention relates to asymmetric liposomes for high encapsulation efficiency of nucleic acids and hydrophilic anionic compounds, and to a method for preparing same, and specifically, to asymmetric liposomes consisting of a cationic lipid having a small head group as an internal lipid and a neutral or PEGylated lipid having a big head group as an external lipid, wherein nucleic acids and/or anionic compounds are encapsulated in the internal lipid. According to the present invention, asymmetric liposomes, in which nucleic acids and hydrophilic anionic compounds are encapsulated with high efficiency, may be prepared, and thus the same may be used for various purposes, such as gene therapy, and the delivery of hydrophilic anionic drugs which are difficult to prepare as prodrugs, and drug delivery, imaging, etc. can be carried out by encapsulating a fluorescent contrast agent in the liposome. | 06-13-2013 |
Bruno Amir, Charenton Le Pont FR
Patent application number | Description | Published |
---|---|---|
20120281183 | Method for Determining Binocular Performance of a Pair of Spectacle Lenses - A method of determining binocular performance of a pair of spectacle lenses comprises: a eyes characteristics providing step, a pair of spectacle lenses providing step, a environment providing step, a cyclopean eye positioning step, a binocular performance criteria defining step, and a binocular performance criteria determining step, wherein the cyclopean eye position is customized. | 11-08-2012 |
20120287405 | Method for Determining Binocular Performance of a Pair of Spectacle Lenses - A method of determining binocular performance of a pair of spectacle lenses comprises: a eyes characteristics providing step, a pair of spectacle lenses providing step, a environment providing step, a binocular performance criteria selecting step, and a binocular performance criteria determining step, wherein the at least one binocular performance criterion is selected among one or a combination of the following criteria groups consisting of central vision criteria group and/or peripheral vision criteria group. | 11-15-2012 |
20140347626 | Process Of Determination Of A Semi - Finished Blank - Method for determining a semi-finished lens blank, comprising the steps consisting of:—determining, for a given material, a set of faces (S-i , S | 11-27-2014 |
Bruno Amir, Paris FR
Patent application number | Description | Published |
---|---|---|
20140313475 | Active System of Vision and Associated Method for Improving Visual Comfort to a Wearer - Ophthalmic lens comprising: a primary zone on a first face; a secondary zone on the first face between said primary zone and the peripheral edge of the lens; first and second regions forming a partition of the secondary zone, which are contiguous and alternate with a pitch. A spectacle eyeglass obtained from said lens produces a first ophthalmic correction in the primary zone and in the first regions, and a second ophthalmic correction in the second regions different from said first ophthalmic correction. An active system of vision comprises an occultation device comprising: a selection device for selecting the wearer's viewing state; an optical occultation system to occult alternatively a first group and a second group according to the wearer's viewing state selected by the selection device, the first group comprising at least the primary zone and the first regions, and the second group comprising at least the second regions. | 10-23-2014 |
Shahzada Amir, Vienna AT
Patent application number | Description | Published |
---|---|---|
20150056209 | PEPTIDE MIMOTOPES TO OXIDATION SPECIFIC EPITOPES - Provided herein are peptide mimotopes that are useful for generating antibodies and in the preparation of vaccines and diagnostics for treating and diagnosing coronary artery disease. | 02-26-2015 |